Xeligekimab: First Approval: Xeligekimab: First Approval: H. A. Blair et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 97, doi. 10.1007/s40265-024-02125-1
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2025 AND VI 85 AND IP 1
Results: 10
1
2
Arimoclomol: First Approval: Arimoclomol: First Approval: S. J. Keam.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 111, doi. 10.1007/s40265-024-02129-x
- By:
- Publication type:
- Article
3
Xanomeline/Trospium Chloride: First Approval: Xanomeline/Trospium Chloride: First Approval: Y. Y. Syed.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 103, doi. 10.1007/s40265-024-02126-0
- By:
- Publication type:
- Article
4
Drugs in Development to Manage Acute Pain: Drugs in Development to Manage Acute Pain: B. Oliver et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 11, doi. 10.1007/s40265-024-02118-0
- By:
- Publication type:
- Article
5
Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes: Updates on Mpox Management: Y. Rizk et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 1, doi. 10.1007/s40265-024-02117-1
- By:
- Publication type:
- Article
6
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations: Treatment of Advanced-Phase CML: E. Atallah et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 41, doi. 10.1007/s40265-024-02108-2
- By:
- Publication type:
- Article
7
Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis: Self-Administered Outpatient Parenteral Antimicrobial Therapy in TB: A. Rauch et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 87, doi. 10.1007/s40265-024-02122-4
- By:
- Publication type:
- Article
8
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations: Immunogenicity and Its Impact on Effectiveness of Therapeutic Antibodies Used in IBD: O. H. Nielsen et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 67, doi. 10.1007/s40265-024-02115-3
- By:
- Publication type:
- Article
9
Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy: Moderate-Intensity Statin Plus Ezetimibe: S. Li et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 51, doi. 10.1007/s40265-024-02113-5
- By:
- Publication type:
- Article
10
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections: Treatment Approaches for Carbapenem-Resistant A. baumannii Infections: A. Iovleva et al.
- Published in:
- Drugs, 2025, v. 85, n. 1, p. 21, doi. 10.1007/s40265-024-02104-6
- By:
- Publication type:
- Article